Sung-yon Lim Overview
- Company
- Hanall Biopharma
- Primary Position
-
Board Member &...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Sung-yon Lim General Information
Biography
Mr. Sung-Yon Lim serves as Chief Financial Officer at Hanall Biopharma Company. He served as a board member at ImmunoMet. He, MM, joined ImmunoMet's Board of Directors in February 2019. He brings over 20 years of finance and accounting experience. He currently serves as Director of the Finance Planning Division at Hanall Biopharma. Prior to this, he worked in a variety of positions at Daewoong Pharmaceutical Company in the areas of accounting, financial strategy, and purchasing. He earned his Bachelor of Business Administration from Hong-Ik University in Seoul, Republic of Korea, and his Master of Management at KAIST, the Korea Advanced Institute of Science and Technology, also in Seoul.
Contact Information
Address
- 12 Bongeunsa-ro 114-gil
- Gangnam
- Seoul, 06170
- South Korea
Sung-yon Lim Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Hanall Biopharma | Company | Board Member & Managing Director | Seoul, South Korea | Drug Delivery |
Sung-yon Lim Board Seats (1)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Hanall Biopharma | Drug Delivery | Publicly Held | Corporate Backed or Acquired | Seoul, South Korea |
Sung-yon Lim Lead Partner on Deals (2)
Sung-yon Lim has been the lead partner on 2 deals. Their latest deal was with ImmunoMet, a drug discovery company. The deal was made for on 05-Feb-2016.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| ImmunoMet | 05-Feb-2016 | Early Stage VC (Series A) | Completed | Drug Discovery | Houston, TX | |
| ImmunoMet | 01-Aug-2015 | Completed | Drug Discovery | Houston, TX |
Sung-yon Lim Network (34)
Board Members (17)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Andrew Kim | ImmunoMet | Incon Company | Houston, TX | |
| Paul Lammers MD | ImmunoMet | Self | Houston, TX | |
| Hanall Biopharma | Self | Seoul, South Korea | ||
| Hanall Biopharma | Self | Seoul, South Korea | ||
| ImmunoMet | Self | Houston, TX |
Portfolio Executives (17)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Sanghee Yoo Ph.D | ImmunoMet | Vice President & Head of Biology | 05-Feb-2016 | Houston, TX |
| Marc Rudoltz MD | ImmunoMet | Chief Medical Officer | 05-Feb-2016 | Houston, TX |
| ImmunoMet | Co-Chief Medical Officer | 05-Feb-2016 | Houston, TX | |
| ImmunoMet | Advisor | 05-Feb-2016 | Houston, TX | |
| ImmunoMet | Chief Medical Officer | 05-Feb-2016 | Houston, TX |
Sung-yon Lim FAQs
-
Who is Sung-yon Lim?
Mr. Sung-Yon Lim serves as Chief Financial Officer at Hanall Biopharma Company.
-
How much does Sung-yon Lim typically invest?
Sung-yon Lim's median deal size is .
-
What is Sung-yon Lim’s main position?
Sung-yon Lim’s primary position is Board Member & Managing Director.
-
How many active board seats does Sung-yon Lim hold?
Sung-yon Lim holds a board seat in Hanall Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
